Laser Removal of Age (Sun) Spots on Hands

Inclusion Criteria: * Females or Males, 18 to 60 years of age (inclusive). * Fitzpatrick Skin Type I - III (Appendix 2). * Clinical diagnosis of benign solar lentigines of the hands. * Presence of at least 5 lesions in the treatment area in diameters ranging from 1 to 8 mm. * Has not used any prescription or over the counter topical creams (e.g., hydroquinone, and/or retinoids and/or corticosteroids) used in the treatment of pigmentation in the treatment area within the last 4 weeks. * Willing to refrain from using any prescription or over the counter topical creams used for the treatment of pigmentation (e.g., hydroquinone, and/or retinoids and/or corticosteroids) in the treatment area during the study period. * Must be able to read, understand and sign the Informed Consent Form. * Willing and able to adhere to the treatment and follow-up schedule and before and after treatment care instructions. * Willing to protect and/or have very limited sun exposure and use an approved sunscreen of SPF 50 or higher in the treatment area starting up to 4 weeks before the treatment, every day for the duration of the study, including the follow-up period * Willing to have digital photographs taken of the treatment area * Agree not to undergo any other procedure(s) for the treatment of solar lentigines during the study. * Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at last 3 months prior to enrollment and during the entire course of the study. Exclusion Criteria: * Participation in a study of another device of drug within 6 months prior to enrollment or during the study. * Prior treatment of solar lentigines of the hands, e.g., with Q-Switched laser, IPL, Chemical peel, cryotherapy within 6 months of study participation. * Having pre-malignant or malignant lesions (e.g., pigmented actinic keratosis, lentigo maligna \[12\], lentigo maligna melanoma), or history of a pre-malignant or malignant lesion in the treatment area. * Subject shows signs of actinic bronzing or recent tanning in the treatment area, and unable/unlikely to refrain from tanning during the study. * Skin abnormalities in the treatment area, e.g., cuts, scrapes, wounds, scars, large moles. * Pregnant and/or breastfeeding. * Having an infection, dermatitis or a rash in the treatment area. * Significant concurrent illness, such as diabetes mellitus or cardiovascular disease, e.g., uncontrolled hypertension * Suffering from coagulation disorders or taking prescription anticoagulation medications. * History of keloid scarring, hypertrophic scarring or of abnormal wound healing. * History of immunosuppression/immune deficiency disorders or currently using immunosuppression medications. * History of vitiligo or psoriasis. * History of connective tissue disease, such as systemic lupus erythematosus or scleroderma. * History of seizure disorders due to light. * Any use of medication that is known to increase sensitivity to light, such as tetracycline. * History of radiation to the treatment area or undergoing systemic chemotherapy for the treatment of cancer. * History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation. * Anytime in life, having have used gold therapy (gold salts) for disorders such as rheumatologic disease or lupus. * Current smoker or history of smoking within 2 years of study participation. * As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study. * History of allergy to topical antibiotics.